Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_assertion type Assertion NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_head.
- NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_assertion description "[In patients with MYCN-amplified NB aged > or =18 months, those with tumor with enhanced DDX1 expression and low-NAG expression showed a significantly better outcome than those with low-DDX1 expression or enhanced NAG expression (p = 0.0245, log-rank test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_provenance.
- NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_assertion evidence source_evidence_literature NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_provenance.
- NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_assertion SIO_000772 17028906 NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_provenance.
- NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_assertion wasDerivedFrom befree-20140225 NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_provenance.
- NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_assertion wasGeneratedBy ECO_0000203 NP591443.RACnE3bcY-lVRaZqmHjdX_BI3pJw9owwSMx5GxdFu0eac130_provenance.